The longevity crowd knows NAD+ well. Nicotinamide adenine dinucleotide — a coenzyme that powers cellular energy production and DNA repair — has been a fixture of the supplement world for years, championed by researchers studying aging at the molecular level. Levels decline as we age, and the theory holds that replenishing them could slow or reverse aspects of cellular aging. Oral supplements, IV drips and precursors like NMN have built a billion-dollar industry on the premise. Numbuzin is asking a narrower question: what happens if you put it on your skin?
Honesty requires saying up front that the evidence for topical NAD+ is thin. The molecule is large and does not cross the stratum corneum easily. The research supporting NAD+ as an anti-aging intervention rests almost entirely on oral and intravenous delivery. The concentration here is undisclosed, and independent work on topical NAD+ in cosmetics is sparse. Were NAD+ the only active in this tube, healthy skepticism would be the correct posture, and no amount of longevity-adjacent branding would change that.
But it is not carrying the formula alone — it is one member of an ensemble that would be impressive at three times the price. Niacinamide sits high on the list, and this is where the biochemistry gets genuinely interesting: niacinamide is the most efficient precursor to NAD+ inside the skin, converted through the salvage pathway in a process that is well documented. By including both the end product and the precursor, Numbuzin has built a dual approach — supplying NAD+ directly while also feeding the skin's own production. Whether the topical NAD+ penetrates meaningfully or not, the niacinamide route is established, and it is doing real work regardless.
Then there is the retinol. Positioned well down the list, the concentration is evidently gentle, which is exactly right for periorbital skin that runs up to ten times thinner than the rest of the face. Retinol's ability to stimulate collagen and accelerate turnover is among the most validated claims in dermatology, and even a mild dose applied consistently produces measurable improvement in fine lines across eight to twelve weeks. Gentleness here is a feature, not a compromise — an aggressive retinoid around the eye is how people end up with flaking eyelids and a drawer full of abandoned eye creams.
The peptide complex is where the ambition becomes almost unreasonable for the money. Over thirty peptides, including acetyl tetrapeptide-5 — marketed as EYESERYL, specifically studied for under-eye puffiness via reduced fluid accumulation — and copper tripeptide-1, which has genuine evidence behind it for collagen, elastin and glycosaminoglycan synthesis. Multiple palmitoyl peptides target wrinkle depth through signal mechanisms. Are all thirty present at efficacious concentrations? Almost certainly not, and anyone claiming otherwise is selling something. But a handful working at mild levels, layered onto the retinol and niacinamide, adds up to a multi-pronged approach that most eye creams at this price do not even attempt.
The vehicle is smart too, and it matters more in an eye cream than almost anywhere else. Ceramide NP with cholesterol supports the fragile barrier — and buffers the retinol, which is the same reason the formula does not sting. Three forms of hyaluronic acid deliver hydration at different depths. Macadamia and olive oils bring emollience, shea butter adds occlusive weight without heaviness, and a silicone network gives the whole thing a silky, smoothing slip. Adenosine adds a little extra fine-line support, with gardenia, malt and viola extracts filling the soothing tail. Crucially, the texture lands in a sweet spot: substantial enough to feel like a treatment, light enough that it stays where you put it and does not creep into your eyes overnight.
Users have responded accordingly — the review base is in the high hundreds and consistently praises the same three things: retinol that does not irritate, immediate brightening under the eye, and a rich texture that never turns greasy. The complaint is universal and entirely fair: 10ml is a very small tube, and even at rice-grain doses it runs out in six to eight weeks. Twenty-one dollars is reasonable per month; it just feels like less product than it should be every time you squeeze it.
A few practical notes. This is a nighttime product for most people, applied with the ring finger — the weakest one, which is the point — patted from the inner corner outward along the orbital bone, never onto the lid or lash line. Retinol means it is off-limits during pregnancy and breastfeeding, and it should not be stacked with another retinoid or a strong acid in the same area. The coconut oil and esters mean it is not fungal-acne safe, though that matters less around an eye than on a forehead.
The brand deserves credit for the ambition even where the headline claim outruns the evidence. Numbuzin's founders trained at Amorepacific, Korea's largest beauty company, and the formulation philosophy shows it: layer many mechanisms at gentle concentrations rather than betting everything on one hero at an aggressive dose. It lowers irritation risk while raising the odds that several actives are doing something real.
Approach this as an excellent retinol-niacinamide-peptide eye cream with an intriguing NAD+ addition — rather than as a NAD+ eye cream with supporting players — and your expectations will land where they should. On those terms it delivers more ingredient complexity than products costing five times as much, and the parts that are proven are genuinely proven.
